Overview An estimated 5290 new cases (2100 men and 3190 women) of anal cancer (involving the anus, anal canal, or anorectum) will occur in the United States in 2009, accounting for approximately 1.9% of digestive system cancers, and an estimated 710 deaths due to anal cancer. Although considered to be a rare type of cancer, the incidence rate of invasive anal carcinoma in the United States increased by approximately 1.6-fold for men and 1.5-fold for women from 1973-1979 to 1994-2000 (see Risk Factors, facing page). This manuscript summarizes the NCCN Clinical Practice Guidelines in Oncology for managing squamous cell anal carcinoma, which represents the most common histologic form of the disease. Other types of cancers occurring in the anal region are addressed in other NCCN guidelines (i.e., anal adenocarcinoma and anal melanoma are managed according to the NCCN Clinical Practice Guidelines in Oncology on Rectal Cancer and Melanoma, respectively). Except where noted, the recommendations in these guidelines are classified as category 2A, meaning that uniform NCCN consensus was present among the panel based on lower-level evidence that the recommendation is appropriate. The panel unanimously endorses patient participation in a clinical trial over standard or accepted therapy. Risk Factors Anal carcinoma has been associated with human papilloma virus (HPV) infection (anal-genital warts); history of receptive anal intercourse or sexually transmitted disease; history of cervical, vulvar, or vaginal cancer; immunosuppression after solid organ transplantation or HIV infection; and smoking. Currently, the association between anal carcinoma and persistent infection with a high-risk form...
  • 1.

    Jemal A, Siegel R, Ward E. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225229.

  • 2.

    Johnson LG, Madeleine MM, Newcomer LM. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004;101:281288.

    • Search Google Scholar
    • Export Citation
  • 3.

    Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000;342:792800.

  • 4.

    Frisch M, Glimelius B, van den Brule AJ. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997;337:13501358.

  • 5.

    Daling JR, Madeleine MM, Godefroy Johnson L. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004;101;270280.

    • Search Google Scholar
    • Export Citation
  • 6.

    De Vurst H, Clifford GM, Nascimento MC. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009;124:16261636.

    • Search Google Scholar
    • Export Citation
  • 7.

    Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009;124:23752383.

    • Search Google Scholar
    • Export Citation
  • 8.

    Gervaz P, Allal AS, Villiger P. Squamous cell carcinoma of the anus: another sexually transmitted disease. Swiss Med Wkly 2003;133:353359.

  • 9.

    Dezube BJ. HIV-associated anal squamous cell cancer: an otherwise preventable disease. J Clin Oncol 2006;24:45164517.

  • 10.

    Patel P, Hanson DL, Sullivan PS. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med 2008;148:728736.

    • Search Google Scholar
    • Export Citation
  • 11.

    Cummings BJ, Ajani JA, Swallow CJ. Cancer of the anal region. In: DeVita VT, Lawrence TS, Rosenberg, SA, eds. Cancer: Principles and Practice of Oncology, 8th ed. Philadelphia: Lippincott, Williams & Wilkins; 2008.

    • Search Google Scholar
    • Export Citation
  • 12.

    Nivatvongs S, Stern HS, Fryd DS. The length of the anal canal. Dis Colon Rectum 1981;24:600601.

  • 13.

    Rickert RR, Compton CC. Protocol for the examination of specimens from patients with carcinomas of the anus and anal canal: a basis for checklists. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 2000;124:2125.

    • Search Google Scholar
    • Export Citation
  • 14.

    Greene F, Page D, Fleming I, Fritz A. AJCC Cancer Staging Manual. New York: Springer-Verlag; 2002.

  • 15.

    Fenger C, Fritsch M, Marti MC, Parc R. Tumours of the anal canal. In: Hamilton SR, Aaltonen LA, eds. World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. IARC Press: Lyon; 2000;145155.

    • Search Google Scholar
    • Export Citation
  • 16.

    Jass JR, Sobin LH. Histological typing of intestinal tumours. Heidelberg: Springer-Verlag; 1989.

  • 17.

    Fenger C. Prognostic factors in anal carcinoma. Pathology 2002;34:53578.

  • 18.

    Cummings BJ. Current management of anal canal cancer. Semin Oncol 2005;32(Suppl 9):S123128.

  • 19.

    Gerard JP, Chapet O, Samiei F. Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature. Cancer 2001;92:7784.

    • Search Google Scholar
    • Export Citation
  • 20.

    Boman BM, Moertel CG, O'Connell MJ. Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer 1984;54:114125.

  • 21.

    Bilimoria KY, Bentrem DJ, Rock CE. Outcomes and prognostic factors for squamous-cell carcinoma of the anal cancer: analysis of patients from the National Cancer Data Base. Dis Colon Rectum 2009;52:624631.

    • Search Google Scholar
    • Export Citation
  • 22.

    Fuchshuber PR, Rodriguez-Bigas M, Weber T, Petrelli NJ. Anal canal and perianal epidermoid cancers. J Am Coll Surg 1997;185:494505.

  • 23.

    Frost DB, Richards PC, Montague ED. Epidermoid cancer of the anorectum. Cancer 1984;53:1285.

  • 24.

    Wade DS, Herrera L, Castillo NB, Petrelli NJ. Metastases to the lymph nodes in epidermoid carcinoma of the anal canal studied by a clearing technique. Surg Gynecol Obstet 1989;169:238242.

    • Search Google Scholar
    • Export Citation
  • 25.

    Cotter SE, Grigsby PW, Siegel BA. FDG-PET/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys 2006;65:720725.

  • 26.

    Trautmann TG, Zuger JH. Positron emission tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal. Mol Imaging Biol 2005;7:309313.

    • Search Google Scholar
    • Export Citation
  • 27.

    Pepek JM, Willet CG, Czito BG. Radiation therapy advances for treatment of anal cancer. J Natl Compr Canc Netw 2010;8:123129.

  • 28.

    Frisch M, Goodman MT. Human papillomavirus-associated carcinomas in Hawaii and the mainland U.S. Cancer 2000;88:14641469.

  • 29.

    Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974;17:354356.

    • Search Google Scholar
    • Export Citation
  • 30.

    Cummings BJ, Keane TJ, O'Sullivan B. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 1991;21:11151125.

    • Search Google Scholar
    • Export Citation
  • 31.

    Papillon J, Chassard JL. Respective roles of radiotherapy and surgery in the management of epidermoid carcinoma of the anal margin. Series of 57 patients. Dis Colon Rectum 1992;35:422429.

    • Search Google Scholar
    • Export Citation
  • 32.

    Uronis HE, Bendell JC. Anal cancer: an overview. Oncologist 2007;12:524534.

  • 33.

    Bartelink H, Roelofsen F, Eschwege F. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative groups. J Clin Oncol 1997;15:20402049.

    • Search Google Scholar
    • Export Citation
  • 34.

    Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Coordinating Committee on Cancer Research. Lancet 1996;348:10491054.

    • Search Google Scholar
    • Export Citation
  • 35.

    Flam M, John M, Pajak TF. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996;14:25272539.

    • Search Google Scholar
    • Export Citation
  • 36.

    Crehange G, Bosset M, Lorchel F. Combining cisplatin and mitomycin with radiotherapy in anal carcinoma. Dis Colon Rectum 2006;50:4349.

  • 37.

    Ajani JA, Winter KA, Gunderson LL. Fluorouracil, mitomycin, and radiotherapy vs. fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal. A randomized controlled trial. JAMA 2008;299:19141921.

    • Search Google Scholar
    • Export Citation
  • 38.

    Eng C, Crane CH, Rodriguez-Bigas MA. Should cisplatin be avoided in the treatment of locally advanced squamous cell carcinoma of the anal canal? Nature Clinical Practice Gastroenterology & Hepatology 2009;6:1617.

    • Search Google Scholar
    • Export Citation
  • 39.

    Czito BG, Willett CG. Current management of anal canal cancer. Gastrointestinal Cancers. Curr Oncol Rep 2009;11:186192.

  • 40.

    Ajani JA, Winter KA, Gunderson LL. US Intergroup Anal Carcinoma Trial: tumor diameter predicts for colostomy. J Clin Oncol 2009;27:11161121.

    • Search Google Scholar
    • Export Citation
  • 41.

    James R, Wan S, Glynne-Jones D. A randomised trial of chemoradiation using mitomycin or cisplatin with or without maintenance cisplatin/5-FU in squamous cell carcinoma of the anus. ACT II [abstract]. J Clin Oncol 2009;27(Suppl 1):Abstract LBA4009.

    • Search Google Scholar
    • Export Citation
  • 42.

    Ortholan C, Ramaioli A, Peiffert D. Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy. Int J Radiat Oncol Biol Phys 2005;62:479485.

    • Search Google Scholar
    • Export Citation
  • 43.

    Ferrigno R, Nakamura RA, Dos Santos Novaes PE. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness. Int J Radiat Oncol Biol Phys 2005;61:11361142.

    • Search Google Scholar
    • Export Citation
  • 44.

    Huang K, Haas-Kogan D, Weinberg V, Krieg R. Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal. World J Gastroenterol 2007;13:895900.

    • Search Google Scholar
    • Export Citation
  • 45.

    Konski A, Garcia M Jr, John M. Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08. Int J Radiat Oncol Biol Phys 2008;72:114118.

    • Search Google Scholar
    • Export Citation
  • 46.

    Graf R, Wust P, Hildebrandt B. Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy. Oncology 2003;65:1422.

    • Search Google Scholar
    • Export Citation
  • 47.

    Roohipour R, Patil S, Goodman KA. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum 2008;51:147153.

    • Search Google Scholar
    • Export Citation
  • 48.

    de Bree E, van Ruth S, Dewit LG, Zoetmulder FA. High risk of colostomy with primary radiotherapy for anal cancer. Ann Surg Oncol 2007;14:100108.

    • Search Google Scholar
    • Export Citation
  • 49.

    Baxter NN, Habermann EB, Tepper JE. Risk of pelvic fracture in older women following pelvic irradiation. JAMA 2005;294:25872593.

  • 50.

    Lin A, Ben-Josef E. Intensity-modulated radiation therapy for the treatment of anal cancer. Clin Colorectal Cancer 2007;6:716719.

  • 51.

    Salama JK, Mell LK, Schomas DA. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol 2007;25:45814586.

    • Search Google Scholar
    • Export Citation
  • 52.

    Milano MT, Jani AB, Farrey KJ. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 2005;63:354361.

    • Search Google Scholar
    • Export Citation
  • 53.

    Chen YJ, Liu A, Tsai PT. Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes. Int J Rad Oncol Biol Phys 2005;63:274281.

    • Search Google Scholar
    • Export Citation
  • 54.

    Myerson RJ, Garofolo MC, Naqa IE. Elective clinical target volumes for conformal therapy in anorectal cancer: an Radiation Therapy Oncology Group Consensus Panel Contouring Atlas. Int J Radiat Oncol Biol Phys 2008;74:824830.

    • Search Google Scholar
    • Export Citation
  • 55.

    Hoffman R, Welton ML, Klencke B. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys 1999;44:127131.

    • Search Google Scholar
    • Export Citation
  • 56.

    Fraunholz I, Weiss C, Eberlein K. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy. Int J Radiat Oncol Biol Phys 2009;in press.

    • Search Google Scholar
    • Export Citation
  • 57.

    Chiao EY, Giordano TP, Richardson P, El-Serg HB. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era. J Clin Oncol 2008;26:474479.

    • Search Google Scholar
    • Export Citation
  • 58.

    Seo Y, Kinsella MT, Reynolds HL. Outcomes of chemoradiotherapy with 5-fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients. Int J Radiat Oncol Biol Phys 2009;75:143149.

    • Search Google Scholar
    • Export Citation
  • 59.

    Oehler-Janne C, Huguet F, Provencher S. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy. J Clin Oncol 2008;26:25502557.

    • Search Google Scholar
    • Export Citation
  • 60.

    Klencke BJ, Palefsky JM. Anal cancer: an HIV-associated cancer. Hematol Oncol Clin North Am 2003;17:859872.

  • 61.

    Faivre C, Rougier P, Ducreux M. 5-fluorouracil and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer. Bull Cancer 1999;86:861865.

    • Search Google Scholar
    • Export Citation
  • 62.

    Nigro ND. An evaluation of combined therapy for squamous cell cancer of the anal canal. Dis Colon Rectum 1984;27:763766.

  • 63.

    Cummings BJ, Keane TJ, O'Sullivan B. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 1991;21:11151125.

    • Search Google Scholar
    • Export Citation
  • 64.

    Mullen JT, Rodriguez-Bigas MA, Chang GJ. Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal. Ann Surg Oncol 2007;14:478483.

    • Search Google Scholar
    • Export Citation
  • 65.

    Renehan AG, Saunders MP, Schofield PF, O'Dwyer ST. Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer. Br J Surg 2005;92:605614.

    • Search Google Scholar
    • Export Citation
  • 66.

    Das P, Bhatia S, Eng C. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 2007;68:794800.

    • Search Google Scholar
    • Export Citation
  • 67.

    Nilsson PJ, Svensson C, Goldman S, Glimelius B. Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg 2002;89:14251429.

  • 68.

    Allal AS, Laurencet FM, Reymond MA. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment. Cancer 1999;86:405409.

    • Search Google Scholar
    • Export Citation
  • 69.

    Ellenhorn JD, Enker WE, Quan SH. Salvage abdominoperineal resection following combined chemotherapy and radiotherapy for epidermoid carcinoma of the anus. Ann Surg Oncol 1994;1:105110.

    • Search Google Scholar
    • Export Citation
  • 70.

    Schiller DE, Cummings BJ, Rai S. Outcomes of salvage surgery for squamous cell carcinoma of the anal canal. Ann Surg Oncol 2007;14:27802789.

    • Search Google Scholar
    • Export Citation
  • 71.

    Chessin DB, Hartley J, Cohen AM. Rectus flap reconstruction decreases perineal wound complications after pelvic chemoradiation and surgery: a cohort study. Ann Surg Oncol 2005;12:104110.

    • Search Google Scholar
    • Export Citation
  • 72.

    Cummings BJ, Keane TJ, O'Sullivan B. Metastatic anal cancer: the search for a cure. Onkologie 2006;29:56.

  • 73.

    Ajani JA, Carrasco CH, Jackson DE, Wallace S. Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal. Am J Med 1989;87:221224.

    • Search Google Scholar
    • Export Citation
  • 74.

    Jaiyesimi IA, Pazdur R. Cisplatin and 5-fluorouracil as salvage therapy for recurrent metastatic squamous cell carcinoma of the anal canal. Am J Clin Oncol 1993;16:536540.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 675 474 16
PDF Downloads 48 31 5
EPUB Downloads 0 0 0